These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3750717)

  • 1. [Treatment of phlegmonous and necrotic forms of erysipelas].
    Kuznetsov RV; Klokova RD; Myshkina AK
    Vestn Khir Im I I Grek; 1986 Jun; 136(6):72-5. PubMed ID: 3750717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erysipelas, a large retrospective study of aetiology and clinical presentation.
    Bläckberg A; Trell K; Rasmussen M
    BMC Infect Dis; 2015 Sep; 15():402. PubMed ID: 26424182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Etiology of erysipelas].
    Stöberl C; Söltz-Szöts J
    Wien Klin Wochenschr; 1987 Feb; 99(4):105-7. PubMed ID: 3554775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Carriage of Staphylococcus aureus. A severity factor of erysipelas?].
    Bernard P; Risse L; Mounier M; Bonnetblanc JM
    Ann Dermatol Venereol; 1996; 123(1):12-5. PubMed ID: 8734109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anal colonization of group G beta-hemolytic streptococci in relapsing erysipelas of the lower extremity.
    Eriksson BK
    Clin Infect Dis; 1999 Nov; 29(5):1319-20. PubMed ID: 10524984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Complex treatment of erysipelas in a surgical clinic].
    Iusupov IA; Iafarov RM
    Vestn Khir Im I I Grek; 1986 Jun; 136(6):75-8. PubMed ID: 3750718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiological, bacteriological and complicating features of erysipelas.
    Jorup-Rönström C
    Scand J Infect Dis; 1986; 18(6):519-24. PubMed ID: 3810046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Argon plasma flowing the complex treatment of different forms of erysipelas].
    Shalutko AM; Osmanov EG; Antropova NV; Anchikov GIu
    Khirurgiia (Mosk); 2006; (3):59-62. PubMed ID: 16710243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of bacteriology and serology in the diagnosis of cellulitis and erysipelas.
    Leppard BJ; Seal DV; Colman G; Hallas G
    Br J Dermatol; 1985 May; 112(5):559-67. PubMed ID: 4005155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pristinamycin in the treatment of acute bacterial dermohypodermitis in adults. An open study of 42 patients].
    Bernard P; Risse L; Bonnetblanc JM
    Ann Dermatol Venereol; 1996; 123(1):16-20. PubMed ID: 8734110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Problems of erysipelas. 3. Streptococcal vaccine treatment of relapsing erysipelas.
    Korossy S; Rajka O; Böszörményi J; Gózony M
    Acta Med Acad Sci Hung; 1968; 25(1):51-61. PubMed ID: 5678738
    [No Abstract]   [Full Text] [Related]  

  • 12. [Estimation of efficiency reamberin in the correction of endogenous intoxication syndrome at the patients with the phlegmonous and gangrenous forms of erysipelas on background diabetes mellitus at their surgical treatment].
    Zelenyĭ II; Frolov VM; Peresadin NA
    Khirurgiia (Mosk); 2011; (11):82-6. PubMed ID: 22408807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Erysipelas and impetigo].
    Cribier B
    Rev Prat; 1996 Sep; 46(13):1593-8. PubMed ID: 8949488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The erysipelas problem. II. The properties and aetiological role of streptococcus strains isolated from erysipelas and other dermal diseases.
    Böszörményi J; Szita J; Rajka O; Korossy S; Gózony M
    Acta Med Acad Sci Hung; 1967; 23(4):337-44. PubMed ID: 5600728
    [No Abstract]   [Full Text] [Related]  

  • 15. [Toxic-shock-like-syndrome caused by beta-hemolysing group G streptococci in a multimorbid patient with erysipelas].
    Bomke AK; Vagts DA; Podbielski A
    Dtsch Med Wochenschr; 2006 Feb; 131(6):263-6. PubMed ID: 16463229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erysipelas and group G streptococci.
    Hugo-Persson M; Norlin K
    Infection; 1987; 15(3):184-7. PubMed ID: 3610323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The information value of immunological tests in predicting recurrences of erysipelas].
    Bala MA; Rychnev VE; Tret'iakova NV
    Vrach Delo; 1990 Jun; (6):118-20. PubMed ID: 2399705
    [No Abstract]   [Full Text] [Related]  

  • 18. [Complex treatment of patients with complicated forms of erysipelas].
    Korolev MP; Spesivtsev IuA; Tolstov OA; Bechvaia LD; Chulikov OV
    Vestn Khir Im I I Grek; 2000; 159(4):64-9. PubMed ID: 11011408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunologic aspects of erysipelas].
    Uzhinova EP; Gudina RV; Dovgaliuk TI
    Sov Med; 1986; (6):111-2. PubMed ID: 3750040
    [No Abstract]   [Full Text] [Related]  

  • 20. [Recurrent erysipelas].
    Konopík J
    Med Klin; 1967 Jul; 62(30):1162-4. PubMed ID: 5594894
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.